Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 501: Which of the following properties makes pyridostigmine different from neostigmine?

A. It is more potent
B. It is longer acting (Correct Answer)
C. It produces fewer muscarinic side effects
D. It has no direct action on neuromuscular receptors

Explanation: **Pyridostigmine** and **Neostigmine** are both reversible anticholinesterases belonging to the quaternary ammonium group. While they share many similarities, their pharmacokinetic and pharmacodynamic profiles differ significantly, making Pyridostigmine the preferred agent for the maintenance treatment of Myasthenia Gravis.#### Why the Correct Answer is Right: * **Duration of Action:** Pyridostigmine has a **longer duration of action** (3–6 hours) compared to Neostigmine (2–4 hours) [1]. This is due to its slower rate of hydrolysis from the acetylcholinesterase enzyme. This longer half-life allows for less frequent dosing and smoother control of muscle weakness, especially overnight.#### Why the Other Options are Wrong: * **A. Potency:** Pyridostigmine is actually **less potent** than neostigmine. A 60 mg dose of pyridostigmine is roughly equivalent to 15 mg of oral neostigmine. * **C. Muscarinic Side Effects:** While pyridostigmine is often better tolerated, it still produces significant muscarinic side effects (nausea, abdominal cramps, diarrhea). It does not inherently "produce fewer" side effects; rather, its slower onset makes them less abrupt. * **D. Direct Action:** Both drugs are quaternary amines and possess a **dual mechanism of action**: they inhibit acetylcholinesterase AND have a **direct agonist effect** on nicotinic receptors (Nm) at the neuromuscular junction.#### High-Yield Clinical Pearls for NEET-PG: * **Drug of Choice:** Pyridostigmine is the DOC for the long-term management of **Myasthenia Gravis** [1]. * **Neostigmine Uses:** Preferred for reversing neuromuscular blockade (post-surgery) and treating postoperative paralytic ileus/urinary retention due to its rapid onset. * **Blood-Brain Barrier:** Being quaternary compounds, neither drug crosses the BBB; hence, they lack central nervous system side effects. * **Edrophonium:** The shortest-acting anticholinesterase, used in the **Tensilon Test** for diagnosing Myasthenia Gravis (though now largely replaced by antibody testing).

Question 502: Which of the following H1 blockers has high anticholinergic activity?

A. Cetirizine
B. Chlorpheniramine (Correct Answer)
C. Fexofenadine
D. Astemizole

Explanation: **Explanation:** The question tests the classification of antihistamines based on their generation and side-effect profile. **1. Why Chlorpheniramine is correct:** Chlorpheniramine is a **first-generation H1 antihistamine**. First-generation agents are highly lipophilic, allowing them to cross the blood-brain barrier (causing sedation) and possess a chemical structure similar to drugs that bind to muscarinic receptors. Consequently, they exhibit **significant anticholinergic activity**, leading to side effects like dry mouth, urinary retention, blurred vision, and constipation. Among the first-generation drugs, the ethanolamines (e.g., Diphenhydramine) and alkylamines (e.g., Chlorpheniramine) have the highest anticholinergic potency. **2. Why the other options are incorrect:** * **Cetirizine (Option A):** This is a **second-generation** H1 blocker. These drugs are more polar, do not readily cross the blood-brain barrier, and are highly selective for peripheral H1 receptors. They have minimal to no anticholinergic activity. * **Fexofenadine (Option B):** A second-generation agent (the active metabolite of Terfenadine). It is considered the "least sedating" antihistamine and lacks anticholinergic effects. * **Astemizole (Option D):** A second-generation agent that was withdrawn from the market due to its potential to cause *Torsades de Pointes* (QT prolongation). Like other second-generation drugs, it lacks significant anticholinergic activity. **High-Yield Clinical Pearls for NEET-PG:** * **Anticholinergic Toxidrome:** Remember the mnemonic "Blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone" for first-generation H1 blocker overdose. * **Drug of Choice:** Chlorpheniramine is commonly used in common cold formulations, while Cetirizine/Fexofenadine are preferred for allergic rhinitis to avoid sedation. * **Contraindication:** Avoid first-generation H1 blockers in patients with **Glaucoma** or **Benign Prostatic Hyperplasia (BPH)** due to their potent anticholinergic effects.

Question 503: Which of the following drugs should be given in a patient with acute angle closure glaucoma, except?

A. Pilocarpine (Correct Answer)
B. Clozapine
C. Fluphenazine
D. Paroxetine

Explanation: **Explanation:** Acute Angle-Closure Glaucoma (AACG) is an ophthalmic emergency characterized by a rapid increase in intraocular pressure (IOP) due to the blockage of the drainage angle. The primary goal of treatment is to induce **miosis** (pupillary constriction) to pull the iris away from the trabecular meshwork, thereby opening the angle and facilitating aqueous humor outflow. **Why Pilocarpine is the Correct Answer:** **Pilocarpine** is a direct-acting cholinergic agonist (miotic). It acts on the $M_3$ receptors of the sphincter pupillae muscle, causing miosis. This physical movement of the iris clears the iridocorneal angle, making it the drug of choice for the emergency management of AACG. **Analysis of Incorrect Options (Drugs to be avoided):** The other options are drugs with **anticholinergic (atropine-like) properties**, which are strictly contraindicated in AACG: * **Clozapine:** An atypical antipsychotic with significant muscarinic antagonist activity. * **Fluphenazine:** A typical antipsychotic (phenothiazine) that possesses anticholinergic side effects. * **Paroxetine:** An SSRI that, unlike others in its class, has mild but clinically relevant anticholinergic effects. * **Mechanism of Danger:** Anticholinergic drugs cause **mydriasis** (pupillary dilation). In a predisposed eye, dilation causes the iris to bunch up at the periphery, further narrowing the angle and potentially precipitating a crisis of acute glaucoma. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for AACG:** IV Acetazolamide (to reduce production) + Topical Pilocarpine (to increase drainage). * **Definitive Treatment:** Peripheral Iridotomy (Laser). * **Mydriatics to avoid in Glaucoma:** Atropine, Cyclopentolate, and Tricyclic Antidepressants (TCAs). * **Pilocarpine Side Effect:** Can cause "brow ache" due to ciliary muscle contraction (accommodative spasm).

Question 504: In oral poisoning with carbamate insecticide, which of the following may be hazardous?

A. Pralidoxime (Correct Answer)
B. Atropine
C. Magnesium sulfate purgative
D. Gastric lavage with activated charcoal

Explanation: **Explanation:** The correct answer is **A. Pralidoxime**. **1. Why Pralidoxime is hazardous in Carbamate poisoning:** Carbamates (e.g., Neostigmine, Physostigmine, Carbaryl) cause reversible inhibition of acetylcholinesterase (AChE) by carbamylation of the enzyme's esteratic site [1]. Unlike organophosphates (OP), carbamates do not undergo "aging." Pralidoxime (an oxime) is a cholinesterase reactivator designed to displace the phosphate group in OP poisoning [2]. However, in carbamate poisoning, the enzyme-carbamate bond is transient and dissociates spontaneously. Adding Pralidoxime can be hazardous because: * Oximes themselves have weak anticholinesterase activity, which can worsen the cholinergic crisis. * Specifically, in **Carbaryl** poisoning, oximes significantly increase the toxicity of the carbamate. **2. Why other options are incorrect:** * **B. Atropine:** This is the **drug of choice** for carbamate poisoning. It competitively antagonizes the muscarinic effects of accumulated acetylcholine. * **C. Magnesium sulfate purgative:** Used to hasten the elimination of the unabsorbed poison from the GI tract. It is a standard supportive measure. * **D. Gastric lavage with activated charcoal:** This is a standard decontamination procedure to prevent further absorption of the toxin if the patient presents within the "golden hour." **Clinical Pearls for NEET-PG:** * **Rule of Thumb:** "Atropine for all, Oximes for OP only." * **Exception:** While oximes are generally contraindicated in carbamates, some guidelines suggest they may be used if there is a **mixed poisoning** (OP + Carbamate) or if the specific toxin is unknown, provided Atropine is already administered. * **Key Difference:** Carbamates = Reversible inhibition (No aging); Organophosphates = Irreversible inhibition (Aging occurs).

Question 505: Which of the following can be blocked by atropine, a muscarinic receptor blocker?

A. Increased blood pressure caused by nicotine
B. Increased skeletal muscle strength caused by neostigmine, an acetylcholinesterase inhibitor
C. Bradycardia caused by infusion of acetylcholine (Correct Answer)
D. All of these

Explanation: **Explanation:** **1. Why Option C is Correct:** Atropine is a competitive antagonist of **muscarinic receptors (M1–M5)**. Acetylcholine (ACh) acts on M2 receptors located in the SA and AV nodes of the heart to cause a decrease in heart rate (bradycardia). Since atropine specifically blocks these muscarinic receptors, it prevents ACh from binding, thereby blocking the bradycardic effect. **2. Why Other Options are Incorrect:** * **Option A:** Nicotine increases blood pressure by stimulating **Nicotinic neuronal (Nn) receptors** in the autonomic ganglia and the adrenal medulla (releasing adrenaline). Atropine has no effect on nicotinic receptors; therefore, it cannot block nicotine-induced hypertension. * **Option B:** Neostigmine increases ACh levels at the neuromuscular junction. This ACh acts on **Nicotinic muscle (Nm) receptors** to increase skeletal muscle strength. Atropine does not block Nm receptors (which require neuromuscular blockers like d-tubocurarine). Thus, atropine does not reverse the skeletal muscle effects of cholinesterase inhibitors. * **Option D:** Since options A and B involve nicotinic receptors, this option is incorrect. **Clinical Pearls for NEET-PG:** * **Atropine Flush:** High doses of atropine cause cutaneous vasodilation (atropine flush), though the mechanism is not fully understood (likely non-cholinergic). * **Drug of Choice:** Atropine is the DOC for **symptomatic bradycardia** and **organophosphate poisoning** (to reverse muscarinic symptoms like salivation, lacrimation, and bronchoconstriction). * **Mnemonic for Atropine Toxicity:** "Hot as a hare, red as a beet, dry as a bone, blind as a bat, and mad as a hatter."

Question 506: Which of the following is an example of asymmetric mixed-onium chlorofumarate?

A. Rocuronium
B. Vecuronium
C. Gantacurium (Correct Answer)
D. Atracurium

Explanation: **Explanation:** **Gantacurium** is the correct answer because it belongs to a new class of neuromuscular blocking agents known as **asymmetric mixed-onium chlorofumarates**. Chemically, it is a fumaric acid ester that contains two different (asymmetric) ammonium groups. It was developed to provide an ultra-short duration of action with a rapid onset, similar to Succinylcholine but without the side effects of depolarization. Its metabolism is unique, occurring via rapid non-enzymatic degradation (cysteine adduction) and ester hydrolysis. **Analysis of Incorrect Options:** * **Rocuronium:** An aminosteroid compound. It is an intermediate-acting non-depolarizing agent known for the fastest onset among non-depolarizing drugs, making it suitable for rapid sequence induction. * **Vecuronium:** Also an aminosteroid derivative. It is an intermediate-acting agent that does not cause significant histamine release or cardiovascular instability. * **Atracurium:** A benzylisoquinolinium compound. It is famous for undergoing **Hofmann elimination** (spontaneous molecular degradation), making it safe for patients with renal or hepatic failure. **High-Yield Clinical Pearls for NEET-PG:** * **Gantacurium's** ultra-short duration is its defining feature; it is currently being studied as a non-depolarizing alternative to Succinylcholine. * **Mivacurium** is the shortest-acting *currently used* non-depolarizing blocker, metabolized by plasma cholinesterase. * **Sugammadex** is a specific reversal agent for aminosteroids (Rocuronium > Vecuronium) but has **no effect** on Gantacurium or Atracurium. * **Laudanosine** is a toxic metabolite of Atracurium that can cross the BBB and potentially cause seizures.

Question 507: Beta 2 selective agonists are often effective in which of the following conditions?

A. Angina due to coronary insufficiency
B. Asthma (Correct Answer)
C. Delayed labor
D. All the above

Explanation: **Explanation:** **1. Why Option B is Correct:** Beta-2 ($\beta_2$) receptors are primarily located in the smooth muscles of the bronchi, blood vessels, and uterus. Activation of these G-protein coupled receptors leads to an increase in intracellular cAMP, which causes **smooth muscle relaxation**. In **Asthma**, $\beta_2$ selective agonists (like Salbutamol or Terbutaline) induce bronchodilation, rapidly relieving airway obstruction. This makes them the mainstay for treating acute bronchospasm. **2. Why Other Options are Incorrect:** * **Option A (Angina):** $\beta_2$ agonists are not used in angina. In fact, $\beta$-blockers (especially $\beta_1$ blockers) are the standard treatment for angina as they decrease myocardial oxygen demand. Non-selective $\beta$ agonists could potentially worsen angina by causing reflex tachycardia. * **Option C (Delayed Labor):** This is a common distractor. $\beta_2$ agonists (e.g., Ritodrine, Isoxsuprine) cause uterine relaxation (tocolysis). Therefore, they are used to **arrest premature labor**, not to treat "delayed labor." To treat delayed labor, one would use uterine stimulants like Oxytocin. **3. High-Yield Clinical Pearls for NEET-PG:** * **Tocolytics:** Ritodrine and Terbutaline are specific $\beta_2$ agonists used to delay preterm labor. * **Side Effects:** The most common side effect of $\beta_2$ agonists is **muscle tremors** (due to action on $\beta_2$ receptors in skeletal muscles). Other effects include tachycardia (due to $\beta_1$ cross-reactivity and reflex action) and **hypokalemia** (as they drive $K^+$ into cells). * **Classification:** * **SABA (Short-Acting):** Salbutamol, Levosalbutamol (Rescue therapy). * **LABA (Long-Acting):** Salmeterol, Formoterol (Maintenance therapy).

Question 508: Which of the following drugs is used in this test?

A. Tolazoline (Correct Answer)
B. Clonidine
C. Bismuth
D. Oxymetazoline

Explanation: ***Tolazoline*** - **Tolazoline** is an **alpha-adrenergic blocker** used as a pharmacological adjunct in **Meckel's diverticulum scintigraphy** to inhibit the release of **Tc-99m pertechnetate** from ectopic gastric mucosa. - By blocking gastric acid secretion, it enhances **visualization** of the Meckel's diverticulum by allowing greater accumulation of the radiotracer in the ectopic gastric tissue. *Clonidine* - **Clonidine** is an **alpha-2 agonist** used primarily for **hypertension** and **ADHD**, not for nuclear medicine imaging studies. - It has no role in **Meckel's diverticulum scintigraphy** and would not enhance visualization of ectopic gastric mucosa. *Bismuth* - **Bismuth** compounds are used for **H. pylori eradication** and as **antidiarrheal agents**, not in nuclear imaging procedures. - It would interfere with **Tc-99m pertechnetate** uptake rather than enhance visualization in Meckel's scan. *Oxymetazoline* - **Oxymetazoline** is an **alpha-1 agonist** used as a **nasal decongestant** with vasoconstrictor properties. - It has no application in **nuclear medicine** and would not be beneficial for enhancing Meckel's diverticulum visualization.

Question 509: What is the most important action of beta-blockers in glaucoma?

A. Membrane stabilizing effect
B. Retinal neuron protecting effect
C. Decrease in the production of aqueous humor (Correct Answer)
D. Pupillary constriction

Explanation: ### Explanation **Correct Answer: C. Decrease in the production of aqueous humor** **Mechanism of Action:** Beta-blockers (e.g., Timolol, Betaxolol) are a mainstay in the treatment of Open-Angle Glaucoma. The ciliary epithelium contains **$\beta_2$ receptors** which, when stimulated, increase the production of aqueous humor via the cAMP-protein kinase A pathway. Beta-blockers antagonize these receptors, leading to a **reduction in the formation of aqueous humor** from the ciliary body. This decrease in inflow effectively lowers the Intraocular Pressure (IOP). **Analysis of Incorrect Options:** * **A. Membrane stabilizing effect (MSE):** This is a local anesthetic-like property. In ophthalmology, MSE is actually **undesirable** because it causes corneal anesthesia, leading to a loss of the protective blink reflex and potential corneal ulceration. Drugs like Timolol are preferred because they lack MSE. * **B. Retinal neuron protecting effect:** While some newer drugs (like Brimonidine) are studied for neuroprotection, this is not the primary or "most important" mechanism by which beta-blockers manage glaucoma. * **D. Pupillary constriction:** This is the mechanism of **Miotics (Cholinergic agonists)** like Pilocarpine. Beta-blockers do not affect the sphincter pupillae or ciliary muscle; therefore, they do not cause miosis or cyclospasm (blurring of vision), which is a clinical advantage over pilocarpine. **High-Yield Clinical Pearls for NEET-PG:** * **Timolol:** The prototype non-selective beta-blocker for glaucoma. It is contraindicated in patients with **Asthma or COPD** due to the risk of systemic absorption causing bronchospasm. * **Betaxolol:** A **$\beta_1$-selective** blocker. It is safer for patients with respiratory issues (though still used with caution) but is slightly less efficacious than Timolol because the ciliary body primarily has $\beta_2$ receptors. * **Levobunolol:** The longest-acting topical beta-blocker. * **Key Advantage:** Unlike miotics, beta-blockers do not affect pupil size or accommodation, making them better tolerated in younger patients.

Question 510: Which of the following inhibits the rate-limiting step of norepinephrine synthesis?

A. Cocaine
B. Amphetamine
C. Metyrosine (Correct Answer)
D. Bretylium

Explanation: ### Explanation **Correct Answer: C. Metyrosine** The synthesis of norepinephrine (NE) follows a specific metabolic pathway: **Tyrosine → DOPA → Dopamine → Norepinephrine → Epinephrine.** The **rate-limiting step** in this sequence is the conversion of Tyrosine to DOPA, catalyzed by the enzyme **Tyrosine Hydroxylase**. **Metyrosine** (α-methyl-L-tyrosine) acts as a competitive inhibitor of this enzyme. By blocking the very first step, it effectively depletes the stores of catecholamines in the nerve endings. --- ### Analysis of Incorrect Options: * **A. Cocaine:** It does not inhibit synthesis. Instead, it inhibits **Uptake-1** (the neuronal reuptake transporter), leading to increased concentrations of NE in the synaptic cleft. * **B. Amphetamine:** It acts primarily as an **indirect sympathomimetic**. It displaces NE from storage vesicles into the cytosol and reverses the NET transporter, causing a massive release of NE into the synapse. * **C. Bretylium:** This is an **adrenergic neuron blocker**. It inhibits the release of NE from the nerve terminal into the synapse (similar to Guanethidine) and also has Class III antiarrhythmic properties. --- ### High-Yield NEET-PG Pearls: * **Clinical Use of Metyrosine:** It is primarily used for the preoperative management of **Pheochromocytoma** to reduce catecholamine production and prevent hypertensive crises during surgery. * **VMAT Inhibition:** While Metyrosine inhibits synthesis, **Reserpine** inhibits the storage of NE by blocking the Vesicular Monoamine Transporter (VMAT). * **Final Step:** The conversion of Dopamine to NE occurs *inside* the storage vesicles via **Dopamine β-hydroxylase**. * **Rate-limiting enzyme mnemonic:** Remember **T**yrosine **H**ydroxylase is the **T**op **H**urdle (Rate-limiting).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free